InsidersTradesSigma
Track the Vascular Biogenics Ltd. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 18 April 2023 (Levée d'options). Among the most active insiders: Backenroth Samuel. Every trade is free.
Analysts rate Vascular Biogenics Ltd. Buy (bullish), based on 8 analysts. Average price target: US$118.75.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Vascular Biogenics Ltd. is a biopharmaceutical company focused on developing treatments for vascular diseases. It is listed on NASDAQ.